Dan Li, MD. Ph.D.

Postdoctoral Fellow (2009-2012)

Current position: Clinical Trail Project Manager in the Research Institute of University of Kansas Medical Center

Education

Professional Appointments

Professional Societies

Honors and Awards

Publications

Li D, Gaedigk R, Hart SN, Leeder JS, and Zhong XB. The role of CYP3A4 mRNA transcript with shortened 3’-UTR in hepatocyte differentiation, liver development, and response to drug induction. Molecular Pharmacology, 2012; 81(1): 86-96.

Wang L, Li F, Lu J, Li G, Li D, Zhong XB, Guo GL, and Ma X. The Chinese herbal medicine sophora flavescens activates pregnane X receptor. Drug Metabolism and Disposition, 2010; 38(12):2226-2231.

Poster Presentations

Li D, Hart SN, Peng L, Tregear H, and Zhong XB. Surveying of alternative transcripts and splicing variants of P450 genes in response to xenobiotics by RNA sequencing. Gordon Research Conference on Drug Metabolism, Heldnerness, NH, July 11-16, 2010.

Li D, Hart SN, Peng L, Tregear H, and Zhong XB. RNA-seq reveals alternative transcripts and splicing variants of P450 genes in human hepatoma HepaRG cells in response to xenobiotics. 9^th International ISSX Meeting, Istanbul, Turkey, September 4-8, 2010.

Li D, Gaedigk R, Hart SN, Tregear H, Leeder JS, and Zhong XB. Alternative CYP3A4 mRNA isoforms are related to hepatocyte differentiation, liver development, and response to drugs. Experimental Biology, Washington, DC, April 9-13, 2011.

Peng L, Li D, Lee IH, Visvanathan M, and Zhong XB. RNA-Seq reveals the transcriptome changes at gene and transcript levels after treatment of HepaRG cells and primary human hepatocytes with phenobarbital. 17^th North American Regional ISSX Meeting, Atlanta, GA, October 16-20, 2011.

Li D, Peng L, Lee IH, Li J, Visvanathan M, and Zhong XB. RNA-Seq identifies novel alternative transcripts of cytochrome P450s in human hepatocytes. Experimental Biology, San Diego, CA, April 21-25, 2012.